NR4A1 and breast cancer: Although gynecological cancers, for instance, breast cancer and endometrial carcinomas, are stongly promoted by female hormones, the rate of hormone receptor expression is reported to be significantly less in uterine LMS than in normal uterine smooth muscle (USM).